We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 483

AmeriSourceBergen Takes another Financial Hit for Fake Pharmacy Operation Under False Claims Act
  • FisherBroyles LLP
  • USA
  • October 3 2018

In a recent announcement, the Department of Justice disclosed that AmerisourceBergen Corporation and several of its subsidiaries (collectively "ABC")


FDA Holds Public Meeting on Nutrition Innovation Strategy
  • Hogan Lovells
  • USA
  • August 3 2018

On July 26, 2018, the Food and Drug Administration (FDA) held a public meeting to discuss issues related to the agency's comprehensive multi-year


Boots on the Ground: PIL Task Force Targeting Opioid Providers in the War on Drugs
  • K&L Gates
  • USA
  • April 30 2018

Attorney General Jeff Sessions announced the creation of the Prescription Interdiction & Litigation (“PIL”) Task Force -- which Sessions described as


Escobar The Sequel? Perhaps Coming Soon to SCOTUS
  • Vinson & Elkins LLP
  • USA
  • April 19 2018

On April 16, 2018, the Supreme Court called for the views of the Solicitor General (or “CVSG”) as to whether it should review the Ninth Circuit’s


FDA Announces Plans to Improve Safety and Advance Innovation of Medical Devices
  • Reed Smith LLP
  • USA
  • April 18 2018

On April 17, 2018, FDA announced its plan to launch the Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health (Action Plan)


Materiality Part III: It Is Not Enough That The Government Could Refuse PaymentThe Question Is Whether The Government Would Refuse Payment
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • April 16 2018

In Part II of our series, we discussed government knowledge. When the government knows of a claim’s falsity, but nevertheless pays the claim, the


Enforcement and Litigation Strategies: Skadden’s Eighth Annual Pharmaceutical, Biotechnology and Medical Device Seminar
  • Skadden Arps Slate Meagher & Flom LLP
  • USA
  • March 29 2018

On March 15, 2018, Skadden hosted its Eighth Annual Pharmaceutical, Biotechnology and Medical Device Seminar in Palo Alto, California, which focused


New DOJ Task Force to Take on Opioid Crisis Using the FCA and Other Enforcement Tools
  • McDermott Will & Emery
  • USA
  • March 2 2018

Earlier this week, the US Department of Justice (DOJ) launched a new front in its effort to combat the opioid crisis and explicitly stated that it


Top 7 Legal Challenges Facing Physicians and Hospitals
  • Jackson Lewis PC
  • USA
  • February 21 2018

The American Health Lawyers Association’s 2018 Physicians and Hospitals Law Institute in New Orleans focused on the legal challenges faced by


False Claims Act's "Rigorous" Materiality Standard Enforced by Second Circuit
  • Jones Day
  • USA
  • January 11 2018

A decision by the U.S. Court of Appeals for the Second Circuit reinforces the growing body of case law regarding the strict materiality requirements